Comparative analysis of histone H3 and H4 post-translational modifications of esophageal squamous cell carcinoma with different invasive capabilities

Journal of Proteomics

Volumn 112, Issue , 2015, Pages 180-189

  Zhang, Kai ^a,b,c   Li, Liyan ^b   Zhu, Mengxiao ^b   Wang, Guojuan ^c   Xie, Jianjun ^b   Zhao, Yunlong ^c   Fan, Enguo ^a   Xu, Liyan ^b   Li, Enmin ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c NANKAI UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Histone; Invasive capability; Mass spectrometry; Protein post translational modifications (PTMs)

Indexed keywords

HISTONE H3; HISTONE H4; LYSINE; HISTONE; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COMPARATIVE STUDY; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PHENOTYPE; PROTEIN ACETYLATION; PROTEIN BUTYRYLATION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN PROCESSING; PROTEOMICS; TUMOR INVASION; ACETYLATION; ESOPHAGUS TUMOR; METABOLISM; METHYLATION; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ACETYLATION; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; HISTONES; HUMANS; METHYLATION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84907766773     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.09.004     Document Type: Article

References (35)

1. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
2. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447:425-432.
3. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007, 8:286-298.
4. Barlesi F., Giaccone G., Gallegos-Ruiz M.I., Loundou A., Span S.W., Lefesvre P., et al. Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol 2007, 25:4358-4364.
5. Seligson D.B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005, 435:1262-1266.
6. Seligson D.B., Horvath S., Mcbrian M.A., Mah V., Yu H., Tze S., et al. Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 2009, 174:1619-1628.
7. Elsheikh S.E., Green A.R., Rakha E.A., Powe D.G., Ahmed R.A., Collins H.M., et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 2009, 69:3802-3809.
8. Park Y.S., Jin M.Y., Kim Y.J., Yook J.H., Kim B.S., Jang S.J. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol 2008, 15:1968-1976.
9. Jenuwein T. The epigenetic magic of histone lysine methylation. FEBS J 2006, 273:3121-3135.
10. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005, 37:391-400.
11. Qi Y.J., Chao W.X., Chiu J.F. An overview of esophageal squamous cell carcinoma proteomics. J Proteomics 2012, 75:3129-3137.
12. Toh Y., Yamamoto M., Endo K., Ikeda Y., Baba H., Kohnoe S., et al. Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol Rep 2003, 10:333-338.
13. Tzao C., Sun G.H., Tung H.J., Hsu H.S., Hsu W.H., Wang Y.C., et al. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma. Ann Thorac Surg 2006, 82:396-401. [discussion].
14. Tzao C., Tung H.J., Jin J.S., Sun G.H., Hsu H.S., Chen B.H., et al. Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus. Mod Pathol 2009, 22:252-260.
15. Jensen O.N. Interpreting the protein language using proteomics. Nat Rev Mol Cell Biol 2006, 7:391-403.
16. Sidoli S., Cheng L., Jensen O.N. Proteomics in chromatin biology and epigenetics: elucidation of post-translational modifications of histone proteins by mass spectrometry. J Proteomics 2012, 75:3419-3433.
17. Tan M.J., Luo H., Lee S., Jin F.L., Yang J.S., Montellier E., et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146:1015-1027.
18. Zhang K., Chen Y., Zhang Z., Zhao Y. Identification and verification of lysine propionylation and butyrylation in yeast core histones using PTMap software. J Proteome Res 2009, 8:900-906.
19. Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol Cell Proteomics 2007, 6:812-819.
20. Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., et al. Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark. Nat Chem Biol 2014, 10:365-370.
21. Olsen C.A. Expansion of the lysine acylation landscape. Angew Chem Int Ed Engl 2012, 51:3755-3756.
22. Ong S.E., Mann M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc 2006, 1:2650-2660.
23. Xie J.J., Xu L.Y., Xie Y.M., Zhang H.H., Cai W.J., Zhou F., et al. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer 2009, 124:2549-2558.
24. Chen Y., Kwon S.W., Kim S.C., Zhao Y. Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra. J Proteome Res 2005, 4:998-1005.
25. Zhang F.R., Tao L.H., Shen Z.Y., Lv Z., Xu L.Y., Li E.M. Fascin expression in human embryonic, fetal, and normal adult tissue. J Histochem Cytochem 2008, 56:193-199.
26. Vollmuth F., Geyer M. Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains. Angew Chem Int Ed Engl 2010, 49:6768-6772.
27. Cheng Z., Tang Y., Chen Y., Kim S., Liu H., Li S.S., et al. Molecular characterization of propionyllysines in non-histone proteins. Mol Cell Proteomics 2009, 8:45-52.
28. Pan G., Tian S., Nie J., Yang C., Ruotti V., Wei H., et al. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 2007, 1:299-312.
29. Portela A., Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010, 28:1057-1068.
30. Wei Y.K., Xia W.Y., Zhang Z.H., Liu J.S., Wang H.M., Adsay N.V., et al. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 2008, 47:701-706.
31. Chen C., Zhao M., Yin N., He B., Wang B., Yuan Y., et al. Abnormal histone acetylation and methylation levels in esophageal squamous cell carcinomas. Cancer Invest 2011, 29:548-556.
32. Shechter D., Nicklay J.J., Chitta R.K., Shabanowitz J., Hunt D.F., Allis C.D. Analysis of histones in Xenopus laevis. I. A distinct index of enriched variants and modifications exists in each cell type and is remodeled during developmental transitions. J Biol Chem 2009, 284:1064-1074.
33. Iwasaki W., Tachiwana H., Kawaguchi K., Shibata T., Kagawa W., Kurumizaka H. Comprehensive structural analysis of mutant nucleosomes containing lysine to glutamine (KQ) substitutions in the H3 and H4 histone-fold domains. Biochemistry 2011, 50:7822-7832.
34. I H, Ko E., Kim Y., Cho E.Y., Han J., Park J., et al. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 2010, 19:566-573.
35. Tachiwana H., Kagawa W., Osakabe A., Kawaguchi K., Shiga T., Hayashi-Takanaka Y., et al. Structural basis of instability of the nucleosome containing a testis-specific histone variant, human H3T. Proc Natl Acad Sci 2010, 107:10454-10459.